MOLMED S.P.A.

GENERA

Pharmaceutical preparations for use in gene therapy for the treatment of tumors, haematological malignancies and genetic diseases;Medical devices for cell manipulation, namely, closed systems comprised of sterile plastics and tubes and mechanical parts consisting of peristaltic pumps that allow cell incubation, cell washing, cell expansion and cell concentration;Medical research and consulting in the field of cell and gene therapy, molecular medicine, cancer treatment, AIDS treatment, genetic disorders treatment and angiogenic disorders treatment; genetic engineering laboratory and biomedical laboratory;

GENERA

Pharmaceutical preparations for use in gene therapy for the treatment of tumors, haematological malignancies and genetic diseases;Medical devices for cell manipulation, namely, closed systems comprised of sterile plastics and tubes and mechanical parts consisting of peristaltic pumps that allow cell incubation, cell washing, cell expansion and cell concentration;Medical research and consulting in the field of cell and gene therapy, molecular medicine, cancer treatment, AIDS treatment, genetic disorders treatment and angiogenic disorders treatment; genetic engineering laboratory and biomedical laboratory;

MOLMED

Cells for medical or clinical use, namely for use in respect to heamatopietic malignancies, namely HIV replication and solid tumors;Color is not claimed as a feature of the mark.;Scientific research in the fields of HIV and cancer;

ZAFIRIDE

Pharmaceutical preparations for treating neoplasia;

ZALMOXIS

Pharmaceutical preparations for gene and cell therapy, pharmaceutical preparations for treating leukaemia and other haematological and neoplasia disorders;